NFKB1 and inflammatory bowel disease: Our data also show that knock-down of NF-κB (p65) or Sp1 by siRNA can significantly decrease SPAK expression levels, confirming their importance in the regulation of SPAK expression and indicating their potential as a target for the treatment of inflammatory diseases such as IBD [52], [64], [65], [66], [67].